Clinical infection with Strongyloides sterocoralis following etanercept use for rheumatoid arthritis.
Boatright
M David
MD
Wang
Benjamin W E
BW
D000818:Animals; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology / Q000469:parasitology*; D000068800:Etanercept; D005243:Feces / Q000469:parasitology; D006801:Humans; D016867:Immunocompromised Host; D007074:Immunoglobulin G / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor; D017171:Strongyloides stercoralis / Q000276:immunology / Q000302:isolation & purification*; D013322:Strongyloidiasis / Q000209:etiology* / Q000276:immunology
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept